You are here

  • Home
  • Archive
  • Volume 23, Issue 4
  • Role of Gefitinib in Patients With Recurrent or Metastatic Cervical Carcinoma Ineligible or Refractory to Systemic Chemotherapy: First Study From Asia

Alerts

Article menu
Download PDFPDF
Cervical Cancer
Role of Gefitinib in Patients With Recurrent or Metastatic Cervical Carcinoma Ineligible or Refractory to Systemic Chemotherapy: First Study From Asia
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address